Michael Kharouta, MD
Radiation Oncology · Chicago, ILNPI 1336670322
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,194 of the $5,085 with a category attached, or 62.8%. Teleflex LLC accounts for 63.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $2,782, more than ten times the $21 reported in 2020.
Across 39 payments — averaging $130.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$3K
- Boston Scientific$700
- Bioprotect Medical, Inc.$304
- Sumitomo Pharma America, Inc.$256
- Elekta, Inc.$216
- Mevion_medical_systems_inc$136
- plus $233 from 3 others
What the payments were for
- Speaking & faculty fees$3507%
- Travel & lodging$1,54130%
- Food & beverage$3,19463%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 16 | $3,239 |
| Boston Scientific | 8 | $700 |
| Bioprotect Medical, Inc. | 5 | $304 |
| Sumitomo Pharma America, Inc. | 5 | $256 |
| Elekta, Inc. | 1 | $216 |
| Mevion_medical_systems_inc | 1 | $136 |
| Novartis | 1 | $125 |
| Genentech USA, Inc. | 1 | $96 |
| Myovant Sciences Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barrigel$1,718
- UroLift$1,533
- SPACEOAR VUE$258
- SpaceOAR VUE System - 10mL$169
- ORGOVYX$138
- PTS250$136
- BIOPROTECT BALLOON IMPLANT SYSTEM$125
- KESIMPTA$125
How this compares
$5,085 in reported general payments places this provider in the 85th percentile of 242 radiation oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 18 | $426 |
| Tamsulosin Hcl | 29 | $382 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Chicago
- Sean PitrodaChicago$103K
- Aditya JulooriChicago$73K
- Steven ChmuraChicago$59K
- William SmallChicago$54K
- Ken TatebeChicago$42K
- Sean SachdevChicago$34K
- Yasmin HasanChicago$18K
- Ralph WeichselbaumChicago$11K
- Tarita ThomasChicago$8K
- Gaurav MarwahaChicago$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.